MCM
ELV icon

Moore Capital Management’s Elevance Health ELV Stock Holding History

Moore Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,500
Closed -$6.09M – 527
2024
Q4 		$6.09M Buy
+16,500
New +$6.9M 0.07% 227

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Moore Capital Management's ELV Position: Q1 2026 in Review

Moore Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 65,000 shares — an estimated $22.8M sold.

Moore Capital Management first reported a position in ELV in Q2 2013 and held it in 16 quarters. The position peaked at $23.5M in Q2 2015. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Moore Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Moore Capital Management sold 65,000 Elevance Health shares in Q1 2026, an estimated $22.8M.
  • Moore Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 16 quarters.
  • Moore Capital Management's Elevance Health position peaked at $23.5M in Q2 2015.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.